14.99
Avadel Pharmaceuticals Plc Aktie (AVDL) Neueste Nachrichten
Avadel licenses once-at-bedtime oxybate therapy from XWPharma - Investing.com
Avadel Pharmaceuticals and XWPharma Enter Exclusive License Agreement for Valiloxybate, a Novel Once-at-Bedtime Oxybate for Sleep Disorders - Quiver Quantitative
Avadel Pharmaceuticals Strengthens Sleep Medicine Portfolio with Exclusive License of Valiloxybate from XWPharma Ltd - The Manila Times
Salt-Free Sleep Drug Deal: Avadel Pharma Expands Portfolio with $20M Valiloxybate License for Narcolepsy - Stock Titan
Is Avadel Pharmaceuticals plc currently under institutional pressureJuly 2025 Recap & Reliable Breakout Stock Forecasts - khodrobank.com
Wells Fargo Initiates Avadel Pharmaceuticals at Equalweight With $16 Price Target - MarketScreener
Applying Elliott Wave Theory to Avadel Pharmaceuticals plc2025 Fundamental Recap & Weekly High Return Forecasts - Newser
Is now a turning point for Avadel Pharmaceuticals plcMarket Activity Summary & Breakout Confirmation Trade Signals - Newser
Is Avadel Pharmaceuticals plc a candidate for recovery playEarnings Risk Summary & Smart Swing Trading Alerts - Newser
Is a relief rally coming for Avadel Pharmaceuticals plc holdersQuarterly Risk Review & Expert Curated Trade Setup Alerts - Newser
Will Avadel Pharmaceuticals plc benefit from macro trendsForecast Cut & Advanced Technical Analysis Signals - Newser
Avadel Pharmaceuticals plc stock chart pattern explained2025 Market Outlook & AI Forecast Swing Trade Picks - Newser
Tick level data insight on Avadel Pharmaceuticals plc volatilityJuly 2025 Big Picture & Real-Time Chart Breakout Alerts - Newser
Can you recover from losses in Avadel Pharmaceuticals plcInflation Watch & Free Risk Controlled Daily Trade Plans - Newser
Sector ETF performance correlation with Avadel Pharmaceuticals plcWeekly Volume Report & Weekly High Conviction Ideas - Newser
Will Avadel Pharmaceuticals plc continue its uptrendQuarterly Risk Review & Daily Risk Controlled Trade Plans - Newser
Custom watchlist performance reports with Avadel Pharmaceuticals plcJuly 2025 Short Interest & Proven Capital Preservation Methods - Newser
Will Avadel Pharmaceuticals plc outperform the marketPortfolio Gains Summary & Accurate Trade Setup Notifications - Newser
Smart tools for monitoring Avadel Pharmaceuticals plc’s price action2025 Support & Resistance & Long-Term Growth Stock Strategies - Newser
What earnings revisions data tells us about Avadel Pharmaceuticals plcJuly 2025 Momentum & Fast Gain Swing Alerts - Newser
Predicting Avadel Pharmaceuticals plc trend using moving averagesInsider Selling & Technical Entry and Exit Tips - Newser
Published on: 2025-09-02 22:45:08 - Newser
Is now the right time to enter Avadel Pharmaceuticals plcMarket Volume Summary & Real-Time Market Sentiment Alerts - khodrobank.com
Pullback Watch: Is Avadel Pharmaceuticals plc exposed to political riskMarket Activity Summary & High Return Trade Guides - khodrobank.com
Can Avadel Pharmaceuticals plc benefit from deglobalizationQuarterly Performance Summary & Community Driven Trade Alerts - khodrobank.com
Avadel Pharmaceuticals plc (AVDL)’s LUMRYZ™ Sales Surge 64% in Breakout Quarter - MSN
How to use a screener to detect Avadel Pharmaceuticals plc breakoutsWeekly Trade Review & Accurate Intraday Trade Tips - Newser
Is Avadel Pharmaceuticals plc building a consolidation base2025 Fundamental Recap & Consistent Profit Alerts - Newser
How to read the order book for Avadel Pharmaceuticals plcBond Market & Daily Technical Forecast Reports - Newser
Risk adjusted return profile for Avadel Pharmaceuticals plc analyzedJuly 2025 Selloffs & Real-Time Volume Analysis - Newser
Trend analysis for Avadel Pharmaceuticals plc this weekPortfolio Risk Report & Free Fast Gain Swing Trade Alerts - Newser
Avadel Pharmaceuticals plc Inches Above Key Support — Safe to Hold getLinesFromResByArray error: size == 0 - kangso.co.kr
Avadel Pharmaceuticals plc stock momentum explainedWeekly Gains Report & AI Powered Market Trend Analysis - Newser
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):